nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years
|
Bass, Ann D. |
|
|
49 |
C |
p. |
artikel |
2 |
Anti-MOG antibody associated encephalomyelitis in an HIV-infected patient
|
Mbonde, Amir A. |
|
|
49 |
C |
p. |
artikel |
3 |
A quick assessment of reliable change in fatigue: Reliable change indices of the modified fatigue impact scale – 5 item (MFIS-5)
|
Cozart, J.S. |
|
|
49 |
C |
p. |
artikel |
4 |
Assessing the consistency and validity of self-reported year of diagnosis among participants in a longitudinal study of people with multiple sclerosis
|
Claflin, Suzi B. |
|
|
49 |
C |
p. |
artikel |
5 |
B cell therapy and the use of RNA-based COVID-19 vaccines
|
Vishnevetsky, Anastasia |
|
|
49 |
C |
p. |
artikel |
6 |
Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis
|
Artemiadis, Artemios |
|
|
49 |
C |
p. |
artikel |
7 |
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment
|
Gómez-Moreno, Mayra |
|
|
49 |
C |
p. |
artikel |
8 |
Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis–A systematic review and network meta-analysis
|
Bartosik-Psujek, Halina |
|
|
49 |
C |
p. |
artikel |
9 |
Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
|
Cotchett, Kelly R. |
|
|
49 |
C |
p. |
artikel |
10 |
Co-occurrence of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids and posterior reversible encephalopathy syndrome: a case report
|
Song, Yanna |
|
|
49 |
C |
p. |
artikel |
11 |
COVID-19 in ocrelizumab-treated people with multiple sclerosis
|
Hughes, Richard |
|
|
49 |
C |
p. |
artikel |
12 |
COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?
|
Gelibter, Stefano |
|
|
49 |
C |
p. |
artikel |
13 |
Demographic features, behavioral measures, and clinical factors as predictors of cognitive function in patients with multiple sclerosis
|
Alirezaei, Mohammad |
|
|
49 |
C |
p. |
artikel |
14 |
Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
|
Smith, Laura |
|
|
49 |
C |
p. |
artikel |
15 |
Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab
|
Flores-Gonzalez, Ramon E |
|
|
49 |
C |
p. |
artikel |
16 |
Differential patterns of parafoveal and peripapillary vessel density in multiple sclerosis and neuromyelitis optica spectrum disorder
|
Lee, Ga-In |
|
|
49 |
C |
p. |
artikel |
17 |
Diffusely appearing white matter in multiple sclerosis: Insights from sodium (23Na) MRI
|
Weber, Claudia E. |
|
|
49 |
C |
p. |
artikel |
18 |
Disability and its association with psychological factors in multiple sclerosis patients
|
Mohaghegh, Fahimeh |
|
|
49 |
C |
p. |
artikel |
19 |
Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?
|
Lynch, Sharon |
|
|
49 |
C |
p. |
artikel |
20 |
Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program
|
Blair, Mervin |
|
|
49 |
C |
p. |
artikel |
21 |
Dual task training effects on gait and balance outcomes in multiple sclerosis: A systematic review
|
Morelli, Nathan |
|
|
49 |
C |
p. |
artikel |
22 |
Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients
|
Liu, Lanzhi |
|
|
49 |
C |
p. |
artikel |
23 |
Elevated cerebrospinal fluid β2-microglobulin levels in patients with neuromyelitis optica spectrum disorders
|
Zhang, Lin-Jie |
|
|
49 |
C |
p. |
artikel |
24 |
ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model
|
Towner, Rheal A. |
|
|
49 |
C |
p. |
artikel |
25 |
Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition
|
Lorefice, L. |
|
|
49 |
C |
p. |
artikel |
26 |
Fever is a common onset feature of MOG-IgG associated disorders (MOGAD)
|
Lampros, Alexandre |
|
|
49 |
C |
p. |
artikel |
27 |
“FLAMES: A novel burning entity in MOG IgG associated disease”
|
Jain, Kshiteeja |
|
|
49 |
C |
p. |
artikel |
28 |
Geography of hospital admissions for multiple sclerosis in Greece
|
Dadouli, Katerina |
|
|
49 |
C |
p. |
artikel |
29 |
Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial
|
Reen, Gurpreet K |
|
|
49 |
C |
p. |
artikel |
30 |
Living with severe multiple sclerosis: Cost-effectiveness of a palliative care intervention and cost of illness study
|
Rosato, Rosalba |
|
|
49 |
C |
p. |
artikel |
31 |
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment
|
Garbo, Riccardo |
|
|
49 |
C |
p. |
artikel |
32 |
MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a
|
Sormani, Maria Pia |
|
|
49 |
C |
p. |
artikel |
33 |
Mental symptoms in MS (MeSyMS): Development and validation of a new assessment
|
Filser, Melanie |
|
|
49 |
C |
p. |
artikel |
34 |
Multiple Sclerosis does not affect the muscular strength of the pelvic floor during pregnancy a case control study.
|
Lourenço, Gisele Alexandre |
|
|
49 |
C |
p. |
artikel |
35 |
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis
|
Capasso, Nicola |
|
|
49 |
C |
p. |
artikel |
36 |
Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy
|
Takai, Yoshiki |
|
|
49 |
C |
p. |
artikel |
37 |
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era
|
Nicholas, Jacqueline A. |
|
|
49 |
C |
p. |
artikel |
38 |
Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review
|
Rodríguez de Antonio, Luis Alberto |
|
|
49 |
C |
p. |
artikel |
39 |
Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability
|
Clarke, Margareta A. |
|
|
49 |
C |
p. |
artikel |
40 |
Periodized versus classic exercise therapy in Multiple Sclerosis: a randomized controlled trial
|
Keytsman, Charly |
|
|
49 |
C |
p. |
artikel |
41 |
Physical Activity in Youth with Multiple Sclerosis receiving the ATOMIC intervention: Social connectedness above all else
|
Ly, Mina |
|
|
49 |
C |
p. |
artikel |
42 |
Predicting conversion to multiple sclerosis by assessing cognitive impairment in radiologically isolated syndrome
|
Domingo-Santos, Ángela |
|
|
49 |
C |
p. |
artikel |
43 |
Predicting falls and injuries in people with multiple sclerosis using machine learning algorithms
|
Piryonesi, S. Madeh |
|
|
49 |
C |
p. |
artikel |
44 |
Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability
|
Abasıyanık, Zuhal |
|
|
49 |
C |
p. |
artikel |
45 |
Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis
|
Chacko, Joseph A |
|
|
49 |
C |
p. |
artikel |
46 |
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients
|
Mallucci, Giulia |
|
|
49 |
C |
p. |
artikel |
47 |
Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study
|
Elser, Holly C. |
|
|
49 |
C |
p. |
artikel |
48 |
Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis
|
Simpson-Yap, Steve |
|
|
49 |
C |
p. |
artikel |
49 |
Simultaneous bilateral optic neuropathy and myelitis revealing paraneoplastic neurological syndrome associated with multiple onconeuronal antibodies
|
Carette, Timothée |
|
|
49 |
C |
p. |
artikel |
50 |
Speech Pathology-Specific Questionnaire for Persons with Multiple Sclerosis (SMS): adaptation, validation and preliminary assessment of the diagnostic potential.
|
Morawska, Joanna |
|
|
49 |
C |
p. |
artikel |
51 |
Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study
|
Cree, Bruce A.C. |
|
|
49 |
C |
p. |
artikel |
52 |
Superlative use within news articles relating to therapies for multiple sclerosis
|
Ferrell, Matthew |
|
|
49 |
C |
p. |
artikel |
53 |
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
|
Messina, Silvia |
|
|
49 |
C |
p. |
artikel |
54 |
The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis
|
Moghadasi, Abdorreza Naser |
|
|
49 |
C |
p. |
artikel |
55 |
Useless hand syndrome: Diagnostic role of electromyography and nerve conduction studies
|
Shields, Lisa B.E. |
|
|
49 |
C |
p. |
artikel |
56 |
Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population
|
Toliver, Joshua C. |
|
|
49 |
C |
p. |
artikel |
57 |
What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM)
|
Carnero Contentti, Edgar |
|
|
49 |
C |
p. |
artikel |
58 |
Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
|
Ehde, Dawn M. |
|
|
49 |
C |
p. |
artikel |
59 |
Working capacity level of patients with multiple sclerosis in Lithuania: Its dynamics and relationship with the employment and lethal outcomes
|
Valadkeviciene, Daiva |
|
|
49 |
C |
p. |
artikel |